Drug intelligence / Profile preview

n-hydroxyguanidine

Development stage
Preclinical
Modality
Small Molecules
01

Overview

N-hydroxyguanidine is a small molecule derivative of guanidine in which a hydroxyl group is attached to one of the nitrogen atoms. This modification imparts unique chemical and biological properties. It acts primarily as both a substrate and inhibitor for nitric oxide synthase (NOS), leading to the production of nitric oxide (NO) from L-arginine or through its own oxidation. The compound has demonstrated antineoplastic (anticancer) and antiviral activities in vitro and in vivo, with derivatives showing enhanced potency compared to hydroxyurea. Additionally, it exhibits antimicrobial activity against resistant bacterial strains and provides cardioprotective effects by reducing ischemic injury in myocardial tissues[2][3][4][7]. Its mechanism involves NO release via NOS interaction, influencing vasodilation, neurotransmission, apoptosis induction in cancer cells, and antimicrobial actions.

Other names
N-HYDROXYGUANIDINEHydroxyguanidine2-Hydroxyguanidine1-hydroxyguanidineGuanidine, hydroxy-Diaminomethylen-hydroxylaminHydroxy-guanidin
02

Targets

NOS3 (eNOS)NOS2 (Nitric Oxide Synthase 2)NOS1 (nNOS)

Beyond the preview

Go deeper on n-hydroxyguanidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-hydroxyguanidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call